/ Jeevan Scientific Technology Gets DCGI Approval, Stocks Up 7.51% ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Wednesday, 21 December 2016

Jeevan Scientific Technology Ltd informed the exchange that the "Office of Drug Control General, India (DCGI)" has approved its Clinical Pharmacology Centre to conduct Bioavailability/ Bioequivalence studies on  December 16, 2016 for a period of three years.

The Centre has four independent clinics and has a total capacity of 132 beds. This Centre will facilitate end-to-end Bioequivalence studies.
or Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717